Product Categories
| Country: | China |
|---|---|
| Tel: | 0755-86210901 |
| Mobile: | 13828841343 |
| E-mail: | |
| QQ: | |
| Skype: | Chat Now! |
| Product Name | MF | CAS | Details |
|---|
| Cefditoren Monohydrate Monocyclic Impurity | Details |
| SYH2055A-3011 | Details |
| Sodium Fusidate Impurity C | Details |
| Metahydroxylamine impurity BMC | Details |
| (R)-N-((S)-1-amino-1-oxobutan-2-yl)-3-(chloromethyl)hexanamide reference substance | Details |
| Galantamine EP Impurity E | C16H19NO3 | 41303-74-6 | Details |
| 2-(dimethylamino)cyclohex-2,5-dien-1,4-dione | C8H9NO2 | 3958-86-9 | Details |
| 3-[(2-Hydroxyethyl)amino]propiononitrile | C5H10N2O | 33759-44-3 | Details |
| Ampicillin Impurity P | Details |
| L-proline cyclization impurity (single configuration) | C10H14N2O2 | 53990-71-9 | Details |
| E-Cefcapene Pivoxil | Details |
| Morpholine nitrate impurity | C4H10N2O4 | Details |
| Penicillin G Potassium Dioxide Impurity | C16H18N2O6S | 18598-31-7 | Details |
| Famotidine Impurity -7 | Details |
| SYF9005-314 | C21H38O4 | 183323-50-4 | Details |
| Penicillin Impurity I | C16H18N2O4S | 3264-88-8 | Details |
| Minoxidil Impurity 2,6-DIAMINO-4-HYDRAZINEYLPYRIMIDINE 1-OXIDE | Details |
| Cefoperazone Impurity P | Details |
| 2-Chloro-M-dimethyl-4-nitrobenzamide | Details |
| (S)-2-(5-((S)-4-hydroxybutan-2-yl)amino)-2,4-dinitrophenyl)amino)propanamide | Details |
| Aminolevulinic Acid Hydrochloride Impurity 1 | Details |
| Delta-2-anti-oxime | Details |
| Penicillin G Potassium Impurity E | C16H20N2O5S | 493-39-0 | Details |
| Piperacillin impurity J | C17H20N4O6 | 2170771-47-6 | Details |
| Impurity Sirolimus-19-ene open ring | C51H79NO13 | 147438-27-5 | Details |
| ATMAA Dimer | Details |
| O-Desmethyl Galantamine | C16H19NO3 | 60755-80-8 | Details |
| Cefdaloxime | C14H15N5O6S2 | 80195-36-4 | Details |
| Pioglitazone condensation aldehyde reference standard | C16H17NO2 | 114393-97-4 | Details |
| SYF9001-013205 | Details |
| N-Nitrosomeropenem | Details |
| SYF9001-013206 | Details |
| Galantamine EP Impurity D | C17H19NO2 | 664995-65-7 | Details |
| Cefotaxime Sodium EP Impurity D | Details |
| Bedaquiline impurity 13 | C32H32N2O2 | 2122862-01-3 | Details |
| Valsartan Potassium Impurity EC | C5H6O5 | 1417576-03-4 | Details |
| Cefixime Polymer Impurity B | Details |
| Sodium 4-sulfobenzoate | C4H5NaO7S | 29454-16-8 | Details |
| Pomalidomide impurity R | Details |
| SYH2055A-3142 | Details |
| Pioglitazone Impurity Q | Details |
| Omeprazole intermediate target impurity 1 | Details |
| (R)-N-((S)-1-amino-1-oxobutane-2-yl)-3-(hydroxymethyl)hexanamide reference substance | Details |
| Cefotaxime impurity A | Details |
| Penicillin G Potassium Impurity F | C15H20N2O3S | 73184-06-2 | Details |
| Pioglitazone N-oxide reference standard | C19H20N2O4S | 145350-09-0 | Details |
| Valsartan potassium impurity ECA | Details |
| Meta-Hydroxyamine Impurity SHC | Details |
| Ampicillin USP Impurity I (Ampicillin Ring Opening Trimer) | Details |
| Proline cyclization impurity (mixed isomers) | C10H14N2O2 | 6708-06-1 | Details |
| Galantamine N-oxide | C17H21NO4 | 199014-26-1 | Details |
| Cefixime Dimer F | Details |
| Spiramycin impurity B | C43H76N2O14 | 249930-66-3 | Details |
| (R)-2-((4-Aminophenethyl)amino)-1-(3-chlorophenyl)ethyl-1-ol | C16H19ClN2O | 391901-43-2 | Details |
| Bromocyclopentane-d9 | Details |
| Brimonidine Tartrate Impurity Q | Details |
| 5-Hydroxy-6-methyl-3,4-diaminobenzidine | Details |
| Aminolevulinic Acid Hydrochloride Impurity 2 | Details |
| 1,3-Dimethyl-1-(methylcarbamoyl)urea | Details |
| Oxacillin Polymer Impurity II | Details |
| (2S,3S,5S)-5-amino-2-(dibenzylamino)-1,6-diphenylhexan-3-ol | C32H36N2O | 156732-15-9 | Details |
| Posaconazole Methyl Carbamate Derivative Impurity | Details |
| Double AE impurities | Details |
| Omeprazole intermediate target impurity 2 | Details |
| 4-(N-formylmethyl)-aminobutanoic acid | C6H12N2O3 | 1096803-44-9 | Details |
| Penicillin G Potassium Oxidation Impurity | C16H18N2O5S | 4052-54-4 | Details |
| Ampicillin ethylenediamine analog | Details |
| Ethyl bile ester reference | Details |
| Aminolevulinic Acid Hydrochloride Impurity 4 | Details |
| Latamoxef Impurity M422 | Details |
| Cefpodoxime proxetil EP impurity 1 | Details |
| 1-(4-Thiophenyl)ethyl-1-one | C8H8OS | 3814-20-8 | Details |
| Mannose Triflate | C15H19F3O12S | 92051-23-5 | Details |
| FosfomycinMethoxy open ring Impurity | 2882846-24-2 | Details |
| Cefixime double side chain △3 isomer | Details |
| 4-O-DesMethyl 4-O-Ethyl TriMethopriM | Details |
| 2-diazinyl-2-phenylethyl acetate | C10H10N2O2 | 22065-57-2 | Details |
| R-Morinidazole | C11H18N4O4 | 898230-59-6 | Details |
| 7-Aminocephalosporanic acid | C10H12N2O5S | 957-68-6 | Details |
| 4-Diazo-3,4-dihydro-7-nitro-3-oxo-1-naphthalenesulfonic acid | C10H5N3O6S | 63589-25-3 | Details |
| 5-(difluoromethoxy)-2-((3,4-dimethoxypyridin-2-yl)methyl)-1H- benzo[d]imidazole | C16H15F2N3O3 | Details |
| Cefixime Dimer D | Details |
| GSK2256294 | C13H18N2O | 138829-43-3 | Details |
| Mesalazine impurity 29 reference standard | C8H7NO4 | 104786-99-4 | Details |
| S-acetylthiorphan | C14H17NO4S | 124735-06-4 | Details |
| Posaconazole Dimethyl Urea Derivative Impurity | Details |
| Posaconazole ethyl carbamate derivative impurity | Details |
| Meta-Hydroxyamine Impurity AA | Details |
| Cefoperazone Impurity 531 | Details |
| PENICILLANYL AMPICILLINAMIDE (USP Ampicillin) | Details |
| 2,5-Dimethoxyphenylhydrazine | C8H12N2O2 | 27861-53-6 | Details |
| Mirodenafil Impurity L | C21H24N4O2S | 1684452-80-9 | Details |
| Amoxicillin Impurity Q | Details |
| 2,5-Dimethoxyphenylhydrazine Hydrochloride | C8H13ClN2O2 | 197590-48-0 | Details |
| Sodium Fusidate Impurity D | Details |
| (S)-2-(5-((R)-4-hydroxybutan-2-yl)amino)-2,4-dinitrophenyl)amino)propanamide | Details |
| Apremilast intermediate 1 APSTYL-1-4 | Details |
| Pyrithione Impurity 6 | C12H10ClNO | 1198414-06-0 | Details |
| 4-(2-Hydroxy-3-(2-methyl-5-nitroimidazol-1-yl)propyl)morpholine-4-oxide | Details |
| Product Total： Product Page： | ||||
| 1 2 3 4 5 6 7 8 | ||||